This compound is a protected phosphoramidite monomer used as a building block in oligonucleotide synthesis. It features a (S)-GNA backbone with a benzoyl-protected cytosine nucleobase and acid-labile dimethoxytrityl (DMT) protecting group.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 885322-06-5
N4-Ac-C-(S)-GNA phosphoramidite
Pharmaceutical intermediate for oligonucleotide synthesis
(S)-GNA-G(iBu) phosphoramidite
Pharmaceutical intermediate for oligonucleotide synthesis
(S)-GNA-A(Bz)-phosphoramidite
Pharmaceutical intermediate for oligonucleotide synthesis
1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
Pharmaceutical intermediate for oligonucleotide synthesis
3'-O-(2-Methoxyethyl)guanosine
Pharmaceutical intermediate for oligonucleotide synthesis
(R)-3-(7-Cyano-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)indolin-1-yl)propyl benzoate oxalate
Pharmaceutical intermediate for silodosin analog
((4-(4-Fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)methyl)triphenylphosphonium bromide
Rosuvastatin intermediate
Methyl 6-bromo-1H-indazole-4-carboxylate
Pharmaceutical intermediate
N-[1-[(2S)-3-[bis(4-methoxyphenyl)-phenylmethoxy]-2-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxypropyl]-2-oxopyrimidin-4-yl]benzamide
IQSXGILXOHYNMA-CIMWKYAKSA-N
CC(C)N(C(C)C)P(OCCC#N)O[C@@H](CN1C=CC(=NC1=O)NC(=O)C2=CC=CC=C2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC